Hansoh Pharmaceutical Group Co Limited/ADR

Over the past 90 days, Hansoh Pharmaceutical Group Co Limited (HNPHY) has generated zero detected cyber incidents and zero red-flag 8-K filings—including no bankruptcy, delisting, restatement, or officer departure disclosures. This clean recent window provides a baseline, though low signal in a 90-day window does not rule out structural risks; the full report extends analysis to 12 months of filings and adds dilution risk scoring, financing history, and AI-detected risk signals that may not surface in headline events. The full $49 Report adds comprehensive dilution trajectory, 8-K context dating back one year, capital structure vulnerability assessment, and machine-detected warning patterns across regulatory submissions.